You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 21, June 6, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Public Health, Other
 •Statistics and Research Methods
 •Genetics
 •Genetics, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Genomics and Public Health Research—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: We agree with Dr Khoury and colleagues. Human genomics is an excellent example of the need to improve the research roadmap and strengthen practice-based research and phase 3 (T3) translation. The best discoveries in human genomics mean little if they cannot be effectively and efficiently delivered to the patients who could benefit. Projects that might connect practice-based researchers with genomics researchers include identifying cancer links between phenotype and genotype and identifying genetic markers for predicting medication response. Identifying the best antihypertensive medication based on genetic disposition may help customize and improve hypertension management.

Moving new discoveries from the laboratory into routine clinical care is a much more complex challenge than has generally been appreciated. It is certainly larger than can be solved at current funding levels available for practice- and community-based research and phase 3 translation. The number of underused discoveries will continue to back up along the . . . [Full Text of this Article]

John M. Westfall, MD, MPH
jack.westfall@uchsc.edu
Department of Family Medicine
University of Colorado at Denver and Health Sciences Center

James Mold, MD, MPH
University of Oklahoma Health Sciences Center
Oklahoma City

Lyle Fagnan, MD
Oregon Health and Science University
Portland



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Genomics and Public Health Research
Muin J. Khoury, Marta Gwinn, and M. Scott Bowen
JAMA. 2007;297(21):2347.
EXTRACT | FULL TEXT  

Genomics and Public Health Research—Reply
Loretta Jones and Kenneth B. Wells
JAMA. 2007;297(21):2348.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Practice-Based Research—"Blue Highways" on the NIH Roadmap
John M. Westfall, James Mold, and Lyle Fagnan
JAMA. 2007;297(4):403-406.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.